Trial intelligence / Profile preview

Roxadustat vs ESA for anemia and vascular calcification in non-dialysis DKD

ChiCTR2100047094Phase 4Recruiting

Sponsor
Shanghai Pudong Hospital
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of roxadustat in anaemia, diabetic glomerulosclerosis and arterial calcification (2 arms), sponsored by Shanghai Pudong Hospital. Primary endpoint: Hemoglobin. Started Jul 2021; status: recruiting.

02

Drugs

roxadustat
03

Conditions

anaemiadiabetic glomerulosclerosisarterial calcification

Beyond the preview

Go deeper on ChiCTR2100047094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call